Billionaire David Einhorn’s Favorite Healthcare Stock

GREENLIGHT CAPITALOne of the top fund managers at the Value Investing Congress was David Einhorn of Greenlight Capital. Einhorn outlined two short ideas, as well as two long ideas. The biggest Einhorn surprise was an investment thesis for a long position in Cigna Corporation (NYSE:CI). Cigna Corp provides employee benefits, such as healthcare products and services.

During his presentation, Einhorn noted that the added complexity of the company has discouraged investors, but with some effort, the HMOs can be pulled apart and analyzed. Healthcare is a rapidly growing part of the economy, with current HMOs having scale and protection from regulatory hurdles. Part of what makes HMOs tough to analyze is the fact that they re-price every year, but while they may have a bad quarter or year, the business model makes money over the long term.

Cigna’s key acquisition of HealthSpring should help with the company’s growth prospects. HealthSpring allows the company to expand into the Medicare market, as well as increasing commercial members. Full integration of the HealthSpring acquisition should allow Cigna to increase its 2013 EPS to $5.85, up from the estimated 2012 EPS of $5.35. HealthSpring will continue to be a key part of Cigna going forward, namely because millions of Americans are aging into Medicare eligibility each year. HealthSpring allowed Cigna to expand Medicare coverage in eleven states.

Cigna Corp does have tough competition flooding the Medicare-Medicaid industry, with the likes of Aetna Inc. (NYSE:AET) purchasing Coventry Health Care, Inc. (NYSE:CVH). In light of that, Cigna Corp has outperformed year to date, while other key health maintenance organizations have been beaten down. Top Cigna competitors Humana Inc. (NYSE:HUM), WellPoint, Inc. (NYSE:WLP) and Aetna are all in the red year to date. Cigna Corp and UnitedHealth Group Inc. (NYSE:UNH) are both up over 12% year to date.

Aetna and Coventry are joining forces, with Aetna acquiring Coventry for $7.3 billion. The deal should be completed in mid-2013 and Aetna, where Coventry is expected to add $0.45 in 2014 and $0.90 in 2015 to Aetna’s EPS. The acquisition will increase Aetna’s Medicaid, Medicare and individual/small group market presence.

On the other hand, Humana has been struggling with rising medical costs due to higher than expected Medicare beneficiaries selecting Humana’s Medicare Advantage plans. Humana appears to have been too conservative in its 2012 Medicare Advantage bids, and as a result, operating EPS is expected to be down to $7.28 in 2012, compared to $8.46 in 2011.

WellPoint has been struggling with losses in members—with a loss of 375,000 self-funded and 400,000 fully insured members expected in 2012. Like Humana, WellPoint is seeing rising medical costs, which is expected to be up 7%. The other key overhang with WellPoint’s shares is the resignation of the company’s CEO, where the stock down 6% since the CEO’s departure.

UnitedHealth has been performing well compared to other peers, with membership gains and access to the Medicare population, thanks to the acquisition of XLHealth. The acquisition is expected to grow long-term EPS between 13%-16%. Last quarter, David Einhorn took a new position in UnitedHealth, in addition to his Cigna position. The 2.3 million shares that Einhorn bought made up 2% of his 13F portfolio.

Einhorn notes that the big concerns dragging down the other HMOs have little impact on Cigna, including concerns of Obamacare and turmoil in Europe. We believe that Cigna Corp’s current medical costs already reflect the impact of new regulations and the company has a very small international segment, although they have aggressive expansion plans.

Einhorn’s position in Cigna, taken in the second quarter, was a new one for Greenlight Capital, representing over 4% of the firm’s second quarter 13F portfolio. At 6.4 million shares, Einhorn is second to only Maverick Capital for most shares owned by the funds we track. Maverick owned 7.1 million shares at the end of 2Q, which was also over 4% of their 13F holdings.

Cigna appears to have some of the better growth prospects and has showed strong performance amidst a tough economic environment. We agree with Einhorn’s thinking that Cigna Corp has a higher return on capital and growth potential internationally, and as a result, deserves to trade a slight premium to its peers, with a P/E of 11 versus the peer average of 9.5.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

10 Things The World Can’t Stand About Americans

Picture Perfect: The 6 Smartphones with the Best Cameras

The 10 Best Countries To Work In the World

A Profitable Day At The Track: 5 Tips For Betting On Horses

Tearing You Apart: 6 Bad Habits That Ruin Relationships

Learning on the Job: The 6 Biggest Mistakes Parents Make

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Burger Kings: The 10 Most Expensive Burgers in the World

The 10 Most Ethnically Diverse Countries in the World

The 10 Most Exclusive Credit Cards in the World

The 10 Most Expensive Cruise Ships in the World

The 10 Fastest Supercomputers in the World

The 10 Best Countries for Doing Business 2015

6 Most Expensive Fruits In The World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!